Home » Topics » Regulatory » Patents

Patents
RSS

Scynexis patents new ciclosporin derivatives for hepatitis C

July 11, 2011

Lundbeck patents new phosphodiesterase 10A inhibitors

July 11, 2011

Mitsubishi Tanabe Pharma discloses new antiplatelet agents

July 11, 2011

Roche discloses novel series of monoamine reuptake inhibitors

July 8, 2011

Novel PI3K inhibitors prepared

July 8, 2011

Dainippon Sumitomo and AstraZeneca claim new Toll-like receptor modulators

July 8, 2011

Novel nuclear receptor related 1 receptor ligands patented by Sanofi

July 8, 2011

Roche discloses new glycogen synthase activators

July 8, 2011

New lysophospholipid S1P1 receptor agonists presented by Almirall

July 8, 2011

Novel phosphodiesterase 10A inhibitors synthesized

July 8, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...